Pharma Deals Review, Vol 2010, No 5 (2010)

Font Size:  Small  Medium  Large

Hospira and Javelin Pharmaceuticals Enter Into Definitive Merger Agreement

Debbie Tranter

Abstract


Hospira Inc. has inked a USD 145 M strategic deal to acquire Javelin Pharmaceuticals. Hospira has outbid the earlier proposal of USD 96 M by Myriad Pharmaceuticals for Javelin.



Add comment

Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.